$TTCM$ INSIDER SHARES LOCKED UNTIL $3.00 SHAREPRICE !
$TTCM$ INSIDER SHARES LOCKED UNTIL $3.00 SHAREPRICE ! ARkNET!
In October of 2016 the TTCM CEO and two other board members (at the time) exchanged a combined 1.3 billion of the common shares they owned into 13,795,104 shares of Series D (non-tradable) preferred stock.
Below are the Conversion Rights for these non-tradable Series D Preferred Shares as shownin the SEC Filings...
*******************
A holder may convert Preferred Shares to common under the following conditions:
Automatic conversion
– each Preferred Share automatically converts to 100 common shares upon the earlier of
· The end of 5 years (5:00 PM EST, October 5, 2021), or
· A change of control
Optional conversion
- After October 5, 2017, each holder may convert each share into 100 shares of common stock immediately following a period of ten consecutive trading days during which the average closing or last sale price exceeds $3.00 per share. Also, each holder may convert into 110 shares of common stock at any time that the shares are listed on a National exchange (for example, the NYSE or NASDAQ).
********************
$TTCM
1
1
TautaChrome Inc (TTCM) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Brixton Metals Expands Thorn Project with New Mineral Claims Brixton Metals Corporation (TSX-V: BBB, OTCQB: BBBXF) has expanded its footprint at the Thorn Project, securing a 100% interest in mineral claims covering 6,446 hectares. These claims, which were previously outside Brixton’s control, sit northwest of the well-known Golden Bear Mine and add ground the company...
Continue Reading
Diving headfirst into the grumbles of this healthcare whirlwind we call Nutex Health. They've set the table to drop their Q2 financials on August 6, right after the bell, followed by a chat with investors the next morning. We're talking bumper-to-bumper business news here, and everyone with a slice in NASDAQ: NUTX better have their ears pricked. Nutex Health: A Mixed Bag...
Continue Reading
Arvore Partners LP Declares Monthly Distribution for October Arvore Partners LP is thrilled to share details about the declaration of its monthly distribution for October. This distribution amounts to $687,365, which translates to an impressive 9.06% annualized yield for its unitholders, marking a 7% increase from the previous month. This consistent growth highlights...
Continue Reading
An Overview of Marathon Petroleum's Earnings Expectations Marathon Petroleum (NYSE: MPC) is gearing up for its quarterly earnings announcement. Investors should prepare for necessary insights leading up to the release of this important announcement. Analysts predict a solid earnings per share (EPS) of $3.23 for the upcoming quarter. While it’s crucial for the company to...
Continue Reading
Transforming Male Infertility Research with PacBio's Revio MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading name in sequencing solutions, is launching an exciting collaboration with the University Hospital of Münster. This partnership is set to leverage long-read whole genome sequencing to significantly advance research in male infertility and rare diseases....
Continue Reading